tirzepatide patent expiry us WHO adds GLP-1RAs to essential medicines list When will the patents on

GLP-1 treatments have shown significant effectiveness in weight management and glycemic control, making them popular choices in diabetes care and obesity treatment

Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury

2025 Advances in Malignant Schwannoma Research and Treatment As of 2025, the management of malignant peripheral nerve sheath tumors (MPNSTs)particularly those associated with Neurofibromatosis type 1 (NF1)is entering a new era, driven by genomic insights, targeted therapies, and novel clinical trial strategies

Int J Epidemiol 44:82736

Most patients require 2 to 6 sessions, with each session costing between $600 and $1,800

If you only track one thing, make it protein